Market Research Report
Osseointegration Implants Market Size, Share & Trends Analysis Report By End Use (ASCs, Hospitals, Dental Clinics), By Product (Dental, Knee, Hip, Spinal Implants), By Region, And Segment Forecasts, 2018 - 2026
|Published by||Grand View Research, Inc.||Product code||744626|
|Published||Content info||102 Pages
Delivery time: 2-3 business days
|Osseointegration Implants Market Size, Share & Trends Analysis Report By End Use (ASCs, Hospitals, Dental Clinics), By Product (Dental, Knee, Hip, Spinal Implants), By Region, And Segment Forecasts, 2018 - 2026|
|Published: October 11, 2018||Content info: 102 Pages||
The global osseointegration implants market size is expected to reach USD 9.3 billion by 2026, according to a new report by Grand View Research, Inc., registering a CAGR of 7.7% during the forecast period. Growing number of joint replacement surgeries among geriatric population, rising adoption of minimally invasive surgeries, and advancement in healthcare facilities are anticipated to drive the osseointegration implants market.
Key players have been using different strategies such as new product launch, acquisitions, partnerships, joint ventures, and agreements to increase their foothold in this market. For instance, in April 2018, Integrum SE introduced a revolutionary OPRA implant system. According to the company, the product will be initially available only in London and would be distributed through London International Patient Services (LIPS), a U.K.-based healthcare treatment organization for international patients seeking treatment.
The osseointegration implants market in developed economies, such as U.S., Germany, France, and Australia, is comparatively mature owing to presence of key market players in these countries and high demand for such products.
On the other hand, emerging countries in Asia and Latin America currently have a moderate adoption rate of these products, presenting lucrative growth opportunities in future. Economic growth and rising disposable income in these countries are anticipated to propel market growth. Manufacturing companies have been investing in these rapidly developing markets, provided pricing and distribution activities are undertaken efficiently.
Some of the key companies in the market are: Medtronic, Stryker Corporation, Zimmer Biomet Holdings, Smith and Nephew Plc., Straumann AG Group, Integrum SE, and ConMed Corporation.